- Home
- ALMU vs TARA Comparison
ALMU vs TARA Comparison
Compare ALMU & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALMU | TARA |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.6M | 268.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALMU | TARA |
|---|---|---|
| Price | $12.20 | $4.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $25.50 | $21.67 |
| AVG Volume (30 Days) | 643.0K | ★ 845.8K |
| Earning Date | 05-06-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $73.87 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.79 | $2.77 |
| 52 Week High | $25.88 | $7.82 |
Technical Indicators
Market Signals| Indicator | ALMU | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 32.77 | 37.61 |
| Support Level | $11.82 | $2.96 |
| Resistance Level | $14.16 | $5.39 |
| Average True Range (ATR) | 0.96 | 0.29 |
| MACD | -0.25 | -0.03 |
| Stochastic Oscillator | 4.28 | 0.49 |
Price Performance
Historical ComparisonAbout ALMU Aeluma Inc.
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).